A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Capecitabine
Related studies linked through entity extraction aliases.
Involved-field Radiotherapy-TNT Combined With PD-1 Inhibitor for pMMR Locally Advanced Rectal Cancer (Neo-Field I)
- Status
- RECRUITING
- Phase
- PHASE2
Evaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE3
QL1706 Injection Plus Bevacizumab and XELOX vs Placebo Plus Bevacizumab and XELOX as First-Line Treatment of Unresectable Metastatic Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Comparing UTD2 Combined With Capecitabine to Capecitabine as Adjuvant Therapy for Non-pCR TNBC Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Oral Metronomic Capecitabine Combined With Pyrotinib in ADC-treated HER2-positive Metastatic Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
JSKN003 Combined Treatment of HER2-positive Gastric Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Randomized, Open-label, Multi-center Phase III Study Comparing the Efficacy of Oral Chemotherapy Combined With Trastuzumab Versus Paclitaxel Combined With Trastuzumab in the Adjuvant Treatment of HER2-positive, Lymph Node-negative Early Breast Cancer Patients(ORCHID-PLUS)
- Status
- RECRUITING
- Phase
- PHASE3
Circulating Tumor DNA Guided Boost Therapy in Early Triple Negative Breast Patients With Residual Disease After Neoadjuvant Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Organ Preservation in Rectal AdenoCa Using Hypofractionated Pelvic RT(Hypo-OPRA)
- Status
- RECRUITING
- Phase
- PHASE2
TC as Adjuvant Therapy After Surgery for Locally Recurrent Resectable Nasopharyngeal Carcinoma: a Single-arm Clinical Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Status
- RECRUITING
- Phase
- PHASE3
A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Real World-clinical Outcomes of Tucatinib, Trastuzumab, and Capecitabine Following Trastuzumab Deruxtecan (T-DXd) for the Treatment of HER2-positive Metastatic Breast Cancer.
- Status
- COMPLETED
- Phase
- N/A
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Radiotherapy + Systemic Therapy as Conversion Therapy for pMMR/MSS T4M0 Colon Cancer（Neo-Color）
- Status
- RECRUITING
- Phase
- PHASE2
Study of JSKN016 Combination Therapy in Inoperable Locally Advanced or Metastatic HER2-Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2